Kurt W. Briner, Director at PROGENICS PHARMACEUTICALS INC (PGNX), sold 33,000 shares at $10.22 ($337K) on 2012-02-03, disclosed to the SEC on 2012-02-03.
Open-market sale of $337k PGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BIOA | BUY | 2016-05-24 | $76K | — | Filing → |
| BIOA | BUY | 2015-08-10 | $240K | — | Filing → |
| BIOA | BUY | 2015-05-08 | $90K | — | Filing → |